Literature DB >> 32056940

Emotionally valenced stimuli impact response inhibition in those with substance use disorder and co-occurring anxiety and depression symptoms.

Alison C Legrand1, Matthew Price2.   

Abstract

BACKGROUND: Substance use disorder (SUD) is associated with impaired response inhibition. Given the deficits in emotion regulation associated with SUD, it is unclear if this impairment is exacerbated by emotionally valenced stimuli. Co-occurring conditions may further exacerbate these impairments as many co-occurring conditions further impact emotion regulation. It was hypothesized that negative stimuli may further impact response inhibition for this population.
METHODS: The current study used the stop-signal task to examine response inhibition to negative, neutral and positive stimuli in a sample of those with a history of SUD and co-occurring depression and anxiety symptoms.
RESULTS: Response inhibition was poorer for negative stimuli relative to neutral stimuli. There was no difference between negative and positive stimuli. Depression severity moderated the difference between response inhibition for negative and neutral stimuli. At elevated depression, response inhibition was worse and there was no difference across emotional stimuli. At low depression, there was a significant difference between negative and neutral stimuli. This effect was not found for anxiety symptoms. LIMITATIONS: Study participants presented with polysubstance use of varying duration and amount. It is unclear whether findings are attributed to specific substances, or substance use broadly. Additionally, happy, angry, and calm facial emotions were used to represent positive, negative, and neutral valences respectively. It is unclear whether these findings are generalizable to other emotional expressions.
CONCLUSION: Results suggested that emotionally valenced stimuli affected response inhibition among those with low symptom severity. At elevated symptom severity, response inhibition to all stimuli were impaired.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Depression; Inhibitory functioning; Response inhibition; Stop signal task; Substance use disorder

Mesh:

Year:  2020        PMID: 32056940      PMCID: PMC7105387          DOI: 10.1016/j.jad.2020.02.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  53 in total

Review 1.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

2.  Fear and stop: a role for the amygdala in motor inhibition by emotional signals.

Authors:  Patricia Sagaspe; Sophie Schwartz; Patrik Vuilleumier
Journal:  Neuroimage       Date:  2011-01-25       Impact factor: 6.556

3.  The role of anxiety sensitivity in reactivity to trauma cues in treatment-seeking adults with substance use disorders.

Authors:  R Kathryn McHugh; Kim L Gratz; Matthew T Tull
Journal:  Compr Psychiatry       Date:  2017-07-31       Impact factor: 3.735

4.  Associations of substance use, abuse, and dependence with subsequent suicidal behavior.

Authors:  G Borges; E E Walters; R C Kessler
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

5.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

6.  Anxiety, cognitive self-evaluation and performance: ERP correlates.

Authors:  Stefania Righi; Luciano Mecacci; Maria Pia Viggiano
Journal:  J Anxiety Disord       Date:  2009-07-22

7.  Inhibition and response to error in remitted major depression.

Authors:  Martin Aker; Ragnhild Bø; Catherine Harmer; Tore C Stiles; Nils Inge Landrø
Journal:  Psychiatry Res       Date:  2015-11-27       Impact factor: 3.222

8.  Executive function deficits associated with current and past major depressive symptoms.

Authors:  Keith Bredemeier; Stacie L Warren; Howard Berenbaum; Gregory A Miller; Wendy Heller
Journal:  J Affect Disord       Date:  2016-06-21       Impact factor: 4.839

9.  Laboratory-induced stress and craving among individuals with prescription opioid dependence.

Authors:  Sudie E Back; Daniel F Gros; Matthew Price; Steve LaRowe; Julianne Flanagan; Kathleen T Brady; Charles Davis; Maryanne Jaconis; Jenna L McCauley
Journal:  Drug Alcohol Depend       Date:  2015-08-28       Impact factor: 4.492

10.  Facial emotion processing in major depression: a systematic review of neuroimaging findings.

Authors:  Anja Stuhrmann; Thomas Suslow; Udo Dannlowski
Journal:  Biol Mood Anxiety Disord       Date:  2011-11-07
View more
  4 in total

1.  The Influence of Vicarious Fear-Learning in "Infecting" Reactive Action Inhibition.

Authors:  Simone Battaglia; Pasquale Cardellicchio; Chiara Di Fazio; Claudio Nazzi; Alessio Fracasso; Sara Borgomaneri
Journal:  Front Behav Neurosci       Date:  2022-07-22       Impact factor: 3.617

2.  Stopping in (e)motion: Reactive action inhibition when facing valence-independent emotional stimuli.

Authors:  Simone Battaglia; Pasquale Cardellicchio; Chiara Di Fazio; Claudio Nazzi; Alessio Fracasso; Sara Borgomaneri
Journal:  Front Behav Neurosci       Date:  2022-09-30       Impact factor: 3.617

3.  Cortical thickness distinguishes between major depression and schizophrenia in adolescents.

Authors:  Zheyi Zhou; Kangcheng Wang; Jinxiang Tang; Dongtao Wei; Li Song; Yadong Peng; Yixiao Fu; Jiang Qiu
Journal:  BMC Psychiatry       Date:  2021-07-20       Impact factor: 3.630

4.  Anger and substance abuse: a systematic review and meta-analysis.

Authors:  Helen V Laitano; Amanda Ely; Anne O Sordi; Felipe B Schuch; Flavio Pechansky; Thiago Hartmann; Juliana B Hilgert; Eliana M Wendland; Lisia Von Dimen; Juliana N Scherer; Alessandra Mendes Calixto; Joana C M Narvaez; Felipe Ornell; Félix H P Kessler
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.